Introduction - What is Mesothelioma?
Mesothelioma, a cancer of the breast, which attacks the lining of the lungs and abdominal cavity, is one of the most notorious types of cancer in the world today. It is a fatal, incurable disease - some statistics report that 9 out of 10 mesothelioma patients will die of the disease within age of 3 Only 5% survive more than five years after diagnosis.
Mesothelioma is flexible to asbestos, a,heat-resistant mineral fiber that was widely distributed, and came in various industries, including in the shipbuilding, construction and mining. Since the connection between mesothelioma and asbestos was discovered to have numerous lawsuits filed by asbestos victims against the company responsible for the exposure. New laws were adopted, the handling.
Since that time, research on the potential mesothelioma treatment was continued, with mixed results. Athe newer therapies will be investigated as a known anti-angiogenic therapy.
Angiogenesis
The term "anti-angiogenesis comes from angiogenesis, a word that means ships the growth and development of new blood. As cancers progress, provided that they quickly outgrow the blood supply to them by the body's blood vessels, and need to grow their own system of vessels, in order to obtain an adequate supply of oxygen and nutrients. Without these new blood vessels that cancer can not continue to grow and spread.
Such as anti-angiogenesis therapy Works
Anti-angiogenesis therapy for the prevention of vessels growth of cancer cells in fresh blood, so slow down or even stop the development of cancer. It does this by focusing on the two chemicals in the body that regulate blood vessel growth: the basic fibroblast growth factor (FGF-2) and vascular endothelial growth factor (VEGF). The latter chemical is particularly important> Mesothelioma patients and tests have shown that people with mesothelioma VEGF exhibit a much greater extent than with other patients of cancers. These results suggest that VEGF mesothelioma, a strong connection to, and may be better to treatments that target VEGF.
of experimental drugs are tested against one of Mesothelioma is bevacizumab. This drug has been tested for use in patients with kidney, breast, ovarian,and prostate, among others. Currently, the results of a study that ended in 2005, and compared the efficacy of bevacizumab against two chemotherapy drugs (gemcitabine and cisplatin) are analyzed and are to be published.
Whether anti-angiogenic therapy is a viable treatment or cure for mesothelioma remains to be seen. While scientists are fighting mesothelioma struggle to find new ways to devastating thousands of people continue to suffer thisDisease.
For more information on mesothelioma and asbestos http://www.mesolawsuit.com visit for resources made available by the Kherkher mesothelioma attorneys of Williams.
Visit : Swine Flu Vaccine